Fidelity purchases $132.7 million in Bitcoin
Key Takeaways
- Fidelity’s FBTC recorded $132.7 million in net inflows on Oct. 14, the largest among all issuers for the day.
- Fidelity’s strong inflows suggest continued institutional and retail accumulation through its platform.
Fidelity, a major US asset manager, saw clients purchase $132.7 million in Bitcoin on Tuesday, demonstrating continued institutional appetite for the leading crypto asset.
The asset manager has enabled Bitcoin exposure in 401(k) retirement plans, allowing clients to incorporate the digital asset into long-term savings strategies.
Alongside peers like BlackRock, Fidelity is strategically acquiring Bitcoin to bolster its portfolio amid fluctuating market conditions. The firm has actively expanded its crypto offerings through spot ETFs and retirement account integrations.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Leverage Liquidations Spike in November 2025: A Warning Story for Crypto Derivatives Traders
- November 2025 saw $20B+ in crypto derivatives liquidated as Bitcoin fell below $100,000, driven by 1001:1 leverage and automated stop-loss mechanisms. - Leverage-driven cascading liquidations pushed Ethereum to four-month lows and exposed systemic risks in unregulated platforms like Hyperliquid and Aster. - Regulators proposed CFTC/SEC role clarifications and domestic leveraged trading, but experts warn structural imbalances persist despite growing retail risk awareness. - Institutional investors shifted
Bitcoin News Update: Propanc’s Cryptocurrency-Driven Cancer Initiative Encounters Doubt from Investors, Stock Falls by 10.5%
- Australia-based Propanc Biopharma secured up to $100M from Hexstone Capital to build a crypto treasury and advance its cancer therapy PRP, targeting first-in-human trials by 2026. - The funding strategy reflects a growing trend in biotech to leverage crypto assets for non-dilutive capital, with Hexstone’s portfolio including Bitcoin , Ether , and Solana . - CEO James Nathanielsz called the move "transformative," aiming to diversify Propanc’s assets while tying capital to clinical milestones, though share
Google introduces Gemini to the Google TV streaming device
A different perspective on the current AI hype
Trending news
MoreCrypto prices
More
